Poxel S.A. (EPA:POXEL)
France · Delayed Price · Currency is EUR 0.1804
-0.0046 (-2.49%)
Sep 11, 2026, 5:35 PM CET
Poxel Market Cap
Poxel has a market cap or net worth of €9.69 million as of September 11, 2026. Its market cap has decreased by -44.26% in one year.
Market Cap
9.69M
Enterprise Value
69.65M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
ChartMarket Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 9.69M, a decrease of -94.98%. That is a compound annual growth rate of -22.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 9.69M | -22.91% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 26.12M |
| genOway Société anonyme | 23.05M |
| Aelis Farma | 13.79M |
| Advicenne | 12.85M |
| Aton | 11.76M |
| NFL Biosciences | 10.90M |
| TME Pharma | 10.11M |
| Biophytis | 6.12M |